(1)
Safety of Subcutaneous Immunotherapy With Tyrosine-Adsorbed House Dust Mite Extracts in Patients With Allergic Disease. Rev Alerg Mex 2017, 64 (1), 52-65. https://doi.org/10.29262/ram.v64i1.233.